Fox Jennifer Lynne bought EBS
March 13, 2024 · Form 4 insider transaction
Fox Jennifer Lynne bought 125,000 shares of Emergent BioSolutions Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$0.00
Total value
N/A
InsiderFox Jennifer Lynne
Role—
SecurityEmployee Stock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 13, 2024
Filing dateMarch 15, 2024
Shares owned after223,169
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Vests in three equal installments beginning on the day prior to the anniversary date of the grant.